Letter written to Joint Secretary, MH & FW reply to GSR 327 (E) dated 03.04.2017 |
|
Letter to Roshni Sohni, Director, NPPA regarding IPDMS notification dated 01.05.2017 |
|
Letter written to Under Secretary-Raised Objections against GSR 302 (E) dated 30.03.2017 |
|
Letter written to DCG(I) regarding Agenda for discussion on 11/05/2017 at FDA Bhavan |
|
Letter written to the member informing date of meeting GSR 327 (E) dated 03.04.2017 and GSR 319 (E) |
|
Regarding Public Notice dated 16.03.2017 |
|
Letter dated 23.03.2017 written to DCG(I) on FDCs declared as Rational |
|
List of centers approved Bio availability/Bioequivalence Studies (till 16-6-2016 |
|
Overview of Regulatory Accreditations |
|
List of NABL Accredited Laboratories |
|
Trends of Import of Bulk drugs, Formulations etc. from 2012-13 to 2015-16 |
|
Trends of Import of Bulk drugs, Formulations, Herbal Products etc. from 2012-13 to 2015-16 |
|